Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Disorders Complicating Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Not applicableActive Not RecruitingNCT03412760
What this trial is testing

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Who this might be right for
Hydrops FetalisBirth DefectFetal Anomaly
University of California, San Francisco 500
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Not applicableStudy completedNCT01869010
What this trial is testing

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

Who this might be right for
HIV Infection
Hospital Italiano de Buenos Aires 30
Testing effectiveness (Phase 2)UnknownNCT00698191
What this trial is testing

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Refractory Systemic Lupus Erythematosus
Nanjing Medical University 20
Not applicableStudy completedNCT03917147
What this trial is testing

Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination

Who this might be right for
Endometrial HyperplasiaEndometrial Neoplasms
University of Campania Luigi Vanvitelli 435
Not applicableLooking for participantsNCT05678543
What this trial is testing

Danish Diabetes Birth Registry 2

Who this might be right for
Pregnancy in DiabeticType 1 DiabetesType 2 Diabetes+5 more
Odense University Hospital 2,500
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Not applicableStudy completedNCT01561885
What this trial is testing

Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways

Who this might be right for
Heart FailureCommunity Acquired PneumoniaVenous Thromboembolism+2 more
Majed Aljeraisy 341
Not applicableStudy completedNCT00118976
What this trial is testing

Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type IDiabetic Nephropathy
Steno Diabetes Center Copenhagen 60
Not applicableLooking for participantsNCT06810739
What this trial is testing

The Women's Screening and Self-Testing Program (PROMETA) Study

Who this might be right for
Human Papilloma Virus Related Cervical Carcinoma
Tulane University 8,445
Post-approval studies (Phase 4)Looking for participantsNCT07404436
What this trial is testing

Rivaroxaban in Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Beijing Friendship Hospital 134
Not applicableEnded earlyNCT04278664
What this trial is testing

Telemedicine in Pregnant Women With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 DiabetesPregnancy in Diabetic
Ana Braescu 5
Large-scale testing (Phase 3)Study completedNCT03774407
What this trial is testing

Vaginal Estriol in Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic Bladder
Texas Tech University Health Sciences Center 21
Large-scale testing (Phase 3)Study completedNCT03643965
What this trial is testing

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 365
Not applicableLooking for participantsNCT01802034
What this trial is testing

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Who this might be right for
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more
The Rogosin Institute 2,000
Next Page